MOMETASONE FUROATE

MOMETASONE FUROATE was reported 42731 times

MOMETASONE FUROATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 123 0.6872
1 TOTAL LUNG CAPACITY INCREASED 158 0.5809
2 EJECTION FRACTION 256 0.4406
3 PRESBYACUSIS 135 0.4383
4 HEART SOUNDS 42 0.4375
5 RHINITIS PERENNIAL 32 0.4000
6 SENSITISATION 273 0.3597
7 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 173 0.3308
8 POOR QUALITY DEVICE USED 2885 0.2873
9 ANTACID THERAPY 35 0.2692
10 TOPICAL STEROID WITHDRAWAL REACTION 95 0.2442
11 CONGENITAL HIATUS HERNIA 47 0.2061
12 PLEURAL THICKENING 138 0.2018
13 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 183 0.1974
14 MALIGNANT MELANOMA STAGE 0 38 0.1818
15 POLYCYSTIC OVARIES 276 0.1778
16 PROLONGED EXPIRATION 46 0.1756
17 SLEEP DISORDER THERAPY 33 0.1667
18 PLEURAL FIBROSIS 147 0.1443
19 RHINITIS ALLERGIC 598 0.1342
20 OBSTRUCTIVE SLEEP APNOEA SYNDROME 192 0.1316
21 ANTICOAGULANT THERAPY 36 0.1268
22 ASTHMA EXERCISE INDUCED 43 0.1236
23 BLOOD MAGNESIUM INCREASED 108 0.1197
24 ANALGESIC THERAPY 34 0.1059
25 BRONCHIAL WALL THICKENING 76 0.1057
26 DUST ALLERGY 102 0.1040
27 SPIROMETRY ABNORMAL 60 0.1003
28 DRUG THERAPY 34 0.1003
29 NASAL CRUSTING 63 0.0971
30 MITE ALLERGY 61 0.0931
31 FACTOR V LEIDEN MUTATION 36 0.0907
32 NASAL POLYPS 444 0.0901
33 ALVEOLAR OSTEITIS 35 0.0827
34 MYOGLOBIN BLOOD INCREASED 121 0.0791
35 EJECTION FRACTION ABNORMAL 95 0.0775
36 MYCOTIC ALLERGY 66 0.0772
37 URINARY TRACT DISCOMFORT 34 0.0738
38 TOTAL LUNG CAPACITY DECREASED 116 0.0726
39 PULMONARY VASCULITIS 38 0.0706
40 SINUS POLYP 40 0.0693
41 BONE CYST 65 0.0693
42 BRONCHIAL OBSTRUCTION 90 0.0641
43 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 129 0.0632
44 OBSTRUCTIVE AIRWAYS DISORDER 698 0.0627
45 NEPHRECTOMY 91 0.0612
46 PRODUCT CONTAINER ISSUE 492 0.0573
47 BRONCHIECTASIS 385 0.0571
48 SPUTUM DISCOLOURED 534 0.0562
49 FULL BLOOD COUNT ABNORMAL 569 0.0537
50 LUNG OPACITY 132 0.0500
51 STEROID WITHDRAWAL SYNDROME 51 0.0499
52 DEAFNESS NEUROSENSORY 164 0.0498
53 CONJUNCTIVITIS ALLERGIC 73 0.0493
54 ALLERGY TO ANIMAL 51 0.0478
55 PLEURITIC PAIN 132 0.0478
56 OSTEOSCLEROSIS 75 0.0476
57 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 34 0.0445
58 SINUS PAIN 103 0.0441
59 PLANTAR FASCIITIS 145 0.0432
60 CHRONIC SINUSITIS 162 0.0431
61 BRAIN NATRIURETIC PEPTIDE INCREASED 131 0.0424
62 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 714 0.0420
63 SARCOIDOSIS 192 0.0404
64 ANIMAL SCRATCH 38 0.0391
65 LUNG HYPERINFLATION 33 0.0384
66 ADJUSTMENT DISORDER 48 0.0369
67 RALES 214 0.0368
68 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 39 0.0367
69 FORCED EXPIRATORY VOLUME DECREASED 104 0.0367
70 EPIGASTRIC DISCOMFORT 138 0.0353
71 NEURITIS 52 0.0337
72 PRODUCT QUALITY ISSUE 4526 0.0333
73 WHEEZING 1958 0.0330
74 SLEEP APNOEA SYNDROME 619 0.0324
75 JAUNDICE CHOLESTATIC 113 0.0320
76 SKIN WEEPING 114 0.0319
77 RESPIRATORY SYMPTOM 90 0.0316
78 BLOOD TEST ABNORMAL 435 0.0309
79 DEVICE MALFUNCTION 2157 0.0307
80 UPPER-AIRWAY COUGH SYNDROME 246 0.0298
81 CATAPLEXY 42 0.0296
82 NEPHROGENIC ANAEMIA 135 0.0291
83 NASAL DISORDER 77 0.0289
84 NASAL OEDEMA 52 0.0288
85 RHINITIS 230 0.0285
86 HYPOMANIA 102 0.0277
87 NO ADVERSE EVENT 4853 0.0268
88 HYPERPARATHYROIDISM SECONDARY 66 0.0263
89 ASTHMA 2921 0.0258
90 CARDIAC MURMUR 222 0.0256
91 PULMONARY FUNCTION TEST DECREASED 111 0.0253
92 BREATH SOUNDS ABNORMAL 124 0.0251
93 CARPAL TUNNEL SYNDROME 352 0.0251
94 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 63 0.0237
95 INCREASED UPPER AIRWAY SECRETION 121 0.0235
96 EXOSTOSIS 212 0.0232
97 NASAL DISCHARGE DISCOLOURATION 32 0.0232
98 NASAL SEPTUM DEVIATION 45 0.0230
99 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 124 0.0228
100 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 757 0.0224
101 INCREASED BRONCHIAL SECRETION 56 0.0219
102 PRE-EXISTING CONDITION IMPROVED 136 0.0218
103 TACHYARRHYTHMIA 54 0.0216
104 TENOSYNOVITIS 59 0.0214
105 PRODUCT DELIVERY MECHANISM ISSUE 114 0.0212
106 TEMPERATURE REGULATION DISORDER 47 0.0211
107 EAR CONGESTION 57 0.0210
108 GASTROOESOPHAGEAL REFLUX DISEASE 1649 0.0205
109 BLOOD PRESSURE DIASTOLIC ABNORMAL 52 0.0204
110 PAINFUL RESPIRATION 49 0.0203
111 ACUTE SINUSITIS 35 0.0203
112 TUNNEL VISION 38 0.0203
113 BRONCHITIS CHRONIC 49 0.0200
114 NASAL DISCOMFORT 158 0.0199
115 PRODUCTIVE COUGH 950 0.0199
116 EOSINOPHIL COUNT INCREASED 164 0.0197
117 BODY TEMPERATURE ABNORMAL 36 0.0195
118 HYPERPHOSPHATAEMIA 42 0.0195
119 SENSATION OF FOREIGN BODY 156 0.0185
120 NORMOCHROMIC NORMOCYTIC ANAEMIA 55 0.0183
121 REBOUND ACID HYPERSECRETION 55 0.0182
122 RHINALGIA 49 0.0178
123 NASAL OBSTRUCTION 33 0.0176
124 DRUG DOSE OMISSION 2907 0.0176
125 SEASONAL ALLERGY 248 0.0175
126 SECRETION DISCHARGE 216 0.0172
127 FIBROMYALGIA 419 0.0172
128 SPUTUM INCREASED 37 0.0171
129 SINUS DISORDER 331 0.0167
130 DYSPNOEA EXERTIONAL 627 0.0166
131 BLOOD IMMUNOGLOBULIN E INCREASED 40 0.0165
132 NASAL CONGESTION 940 0.0160
133 CYST 198 0.0159
134 PARANASAL SINUS DISCOMFORT 60 0.0158
135 ANOSMIA 228 0.0157
136 BLOOD CALCIUM INCREASED 138 0.0157
137 OSTEOPENIA 238 0.0157
138 PNEUMONIA ASPIRATION 386 0.0154
139 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 742 0.0154
140 SNORING 58 0.0153
141 HYPERLIPIDAEMIA 177 0.0148
142 ASPIRATION 162 0.0148
143 CREPITATIONS 43 0.0144
144 HYPERCHOLESTEROLAEMIA 137 0.0142
145 RESPIRATION ABNORMAL 97 0.0141
146 EOSINOPHILIA 245 0.0140
147 SKIN WRINKLING 38 0.0140
148 INFUSION SITE PRURITUS 44 0.0139
149 POLYMYALGIA RHEUMATICA 44 0.0138
150 FOOD ALLERGY 106 0.0137
151 ASTHMATIC CRISIS 50 0.0137
152 SINUSITIS 1391 0.0136
153 BENIGN PROSTATIC HYPERPLASIA 70 0.0135
154 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 962 0.0135
155 DEPRESSIVE SYMPTOM 47 0.0133
156 DYSPHONIA 774 0.0132
157 RESPIRATORY TRACT CONGESTION 207 0.0130
158 BLOOD PRESSURE SYSTOLIC ABNORMAL 32 0.0129
159 MULTIPLE ALLERGIES 100 0.0127
160 HYPOTHYROIDISM 407 0.0127
161 OBESITY 199 0.0125
162 UPPER RESPIRATORY TRACT INFECTION 577 0.0125
163 DYSPNOEA AT REST 36 0.0124
164 ARTERIOSCLEROSIS CORONARY ARTERY 82 0.0124
165 BLADDER PAIN 39 0.0123
166 SINUS CONGESTION 165 0.0122
167 SKIN ATROPHY 70 0.0122
168 CYSTIC FIBROSIS 67 0.0121
169 MASTICATION DISORDER 37 0.0121
170 PULMONARY MASS 177 0.0119
171 EXERCISE TOLERANCE DECREASED 68 0.0118
172 CHEST DISCOMFORT 1207 0.0118
173 HEPATIC CYST 40 0.0118
174 HAEMOPTYSIS 326 0.0117
175 DIASTOLIC DYSFUNCTION 36 0.0117
176 WOUND COMPLICATION 40 0.0116
177 LUNG NEOPLASM 49 0.0115
178 EAR DISORDER 51 0.0111
179 MIDDLE INSOMNIA 208 0.0111
180 SWOLLEN TONGUE 346 0.0111
181 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 578 0.0111
182 END STAGE RENAL DISEASE 200 0.0110
183 THROMBOPHLEBITIS SUPERFICIAL 33 0.0109
184 FLANK PAIN 102 0.0109
185 BLOOD PRESSURE DIASTOLIC INCREASED 50 0.0108
186 BLOOD COUNT ABNORMAL 164 0.0108
187 FOREIGN BODY IN THROAT 34 0.0108
188 BRONCHOSPASM 154 0.0108
189 CHOLECYSTITIS CHRONIC 72 0.0107
190 RHINORRHOEA 695 0.0107
191 OSTEOARTHRITIS 453 0.0107
192 INFUSION SITE SWELLING 67 0.0106
193 SINUS HEADACHE 63 0.0106
194 VASCULITIS 123 0.0105
195 DIVERTICULUM 75 0.0105
196 LOWER RESPIRATORY TRACT INFECTION 480 0.0105
197 ASTHENOPIA 58 0.0105
198 INTERVERTEBRAL DISC DEGENERATION 97 0.0105
199 CANDIDIASIS 42 0.0105
200 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 53 0.0105
201 ECCHYMOSIS 71 0.0103
202 WOUND SECRETION 40 0.0102
203 BODY TEMPERATURE DECREASED 99 0.0100
204 NASAL DRYNESS 63 0.0100
205 INFUSION SITE HAEMORRHAGE 33 0.0100
206 EAR PAIN 195 0.0100
207 COUGH 2805 0.0100
208 CLAVICLE FRACTURE 38 0.0099
209 PHARYNGITIS 123 0.0099
210 CORONARY ARTERY DISEASE 300 0.0099
211 HYPOVENTILATION 32 0.0098
212 GLUCOSE TOLERANCE IMPAIRED 58 0.0098
213 POST-TRAUMATIC STRESS DISORDER 65 0.0097
214 ARTERIOSCLEROSIS 91 0.0097
215 EAR DISCOMFORT 99 0.0096
216 PRODUCT LEAKAGE 54 0.0096
217 BRONCHITIS 711 0.0096
218 DIVERTICULUM INTESTINAL 42 0.0096
219 GLOSSITIS 34 0.0096
220 ROSACEA 44 0.0094
221 RESPIRATORY TRACT INFECTION 245 0.0094
222 CHRONIC KIDNEY DISEASE 708 0.0093
223 TRIGGER FINGER 38 0.0093
224 HIATUS HERNIA 120 0.0093
225 OBSTRUCTION 37 0.0093
226 BURSITIS 112 0.0092
227 BLOOD PRESSURE SYSTOLIC INCREASED 180 0.0092
228 PULMONARY FIBROSIS 177 0.0092
229 SPINAL OSTEOARTHRITIS 81 0.0092
230 ATELECTASIS 89 0.0092
231 TEMPERATURE INTOLERANCE 95 0.0092
232 DEFORMITY 86 0.0092
233 SNEEZING 205 0.0091
234 SCHIZOPHRENIA 111 0.0091
235 POOR QUALITY PRODUCT ADMINISTERED 96 0.0091
236 NEPHROPATHY 85 0.0091
237 NEUROLOGICAL SYMPTOM 52 0.0091
238 ECONOMIC PROBLEM 137 0.0090
239 CHOLELITHIASIS 294 0.0090
240 SKIN LESION 245 0.0089
241 PRODUCT DOSE OMISSION 579 0.0089
242 LIGAMENT RUPTURE 39 0.0088
243 HYPERVENTILATION 51 0.0088
244 EAR INFECTION 234 0.0088
245 MYASTHENIA GRAVIS 71 0.0088
246 SPINAL COLUMN STENOSIS 41 0.0087
247 PAROSMIA 65 0.0086
248 GESTATIONAL DIABETES 41 0.0086
249 APPETITE DISORDER 57 0.0086
250 LIGAMENT SPRAIN 85 0.0086
251 PULMONARY CONGESTION 113 0.0086
252 SENSITIVITY TO WEATHER CHANGE 45 0.0085
253 TYPE 2 DIABETES MELLITUS 287 0.0085
254 ATRIAL FLUTTER 68 0.0085
255 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 146 0.0085
256 PNEUMOTHORAX 135 0.0085
257 PSEUDOMONAS INFECTION 73 0.0085
258 ORAL CANDIDIASIS 111 0.0084
259 POOR QUALITY DRUG ADMINISTERED 54 0.0083
260 ANGIOEDEMA 368 0.0083
261 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 54 0.0083
262 ENURESIS 33 0.0082
263 APHONIA 114 0.0082
264 VARICOSE VEIN 42 0.0081
265 BLOOD POTASSIUM INCREASED 132 0.0081
266 SKIN LACERATION 87 0.0080
267 VITAMIN D DEFICIENCY 78 0.0080
268 POLYP 52 0.0079
269 NEURALGIA 193 0.0079
270 OROPHARYNGEAL DISCOMFORT 71 0.0079
271 PULMONARY ALVEOLAR HAEMORRHAGE 44 0.0078
272 SKIN PLAQUE 66 0.0078
273 BURNING SENSATION 546 0.0078
274 TRICUSPID VALVE INCOMPETENCE 61 0.0077
275 WRIST FRACTURE 91 0.0076
276 VIRAL UPPER RESPIRATORY TRACT INFECTION 36 0.0076
277 GLAUCOMA 145 0.0075
278 COMA 358 0.0075
279 DRUG INTOLERANCE 722 0.0075
280 INFUSION SITE ERYTHEMA 63 0.0075
281 GOUT 133 0.0074
282 METASTASES TO LYMPH NODES 50 0.0074
283 STREPTOCOCCAL INFECTION 41 0.0074
284 PRODUCT ODOUR ABNORMAL 77 0.0073
285 MITRAL VALVE INCOMPETENCE 83 0.0073
286 PRODUCT TASTE ABNORMAL 99 0.0073
287 HYPOPHOSPHATAEMIA 54 0.0073
288 PRODUCT AVAILABILITY ISSUE 166 0.0073
289 THROAT IRRITATION 326 0.0073
290 PRODUCT ADMINISTRATION INTERRUPTED 57 0.0073
291 CONCUSSION 56 0.0072
292 TROPONIN INCREASED 55 0.0072
293 NODULE 94 0.0072
294 RIB FRACTURE 148 0.0072
295 OROPHARYNGEAL PAIN 665 0.0072
296 JOINT INJURY 153 0.0072
297 DYSPNOEA 4038 0.0071
298 SWELLING FACE 463 0.0071
299 HYPOXIA 250 0.0071
300 RESPIRATORY RATE INCREASED 63 0.0071
301 EPISTAXIS 528 0.0071
302 LUNG DISORDER 344 0.0070
303 SCOLIOSIS 43 0.0069
304 RENAL DISORDER 323 0.0069
305 HAND FRACTURE 49 0.0069
306 INFUSION SITE PAIN 89 0.0069
307 HYPERSENSITIVITY 1282 0.0069
308 SLEEP DISORDER 487 0.0069
309 DRY EYE 343 0.0069
310 LEFT VENTRICULAR DYSFUNCTION 46 0.0069
311 DIABETIC NEUROPATHY 34 0.0069
312 HEART RATE ABNORMAL 38 0.0068
313 DERMATITIS CONTACT 77 0.0067
314 BRONCHOPULMONARY ASPERGILLOSIS 52 0.0067
315 ROTATOR CUFF SYNDROME 86 0.0067
316 CONJUNCTIVITIS 124 0.0067
317 TOOTH ABSCESS 68 0.0067
318 ADRENAL INSUFFICIENCY 81 0.0067
319 RENAL CYST 53 0.0067
320 CARDIAC DISORDER 619 0.0066
321 ARTHROPOD BITE 49 0.0066
322 NASOPHARYNGITIS 1215 0.0066
323 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 40 0.0066
324 FOOT FRACTURE 123 0.0065
325 LIVER FUNCTION TEST INCREASED 139 0.0065
326 MUSCLE STRAIN 56 0.0065
327 EMPHYSEMA 65 0.0064
328 SKIN INFECTION 72 0.0064
329 PHARYNGOLARYNGEAL PAIN 34 0.0064
330 CANDIDA INFECTION 108 0.0064
331 LARGE INTESTINE POLYP 44 0.0063
332 TRANSAMINASES INCREASED 141 0.0063
333 UTERINE LEIOMYOMA 46 0.0063
334 ANHEDONIA 165 0.0063
335 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 292 0.0062
336 SOMNAMBULISM 41 0.0062
337 VITAMIN D DECREASED 53 0.0062
338 BLOOD IRON DECREASED 73 0.0061
339 RESTLESS LEGS SYNDROME 111 0.0061
340 NERVE COMPRESSION 56 0.0061
341 IRON DEFICIENCY ANAEMIA 56 0.0061
342 INFLUENZA 674 0.0060
343 MICTURITION URGENCY 69 0.0060
344 VITREOUS FLOATERS 59 0.0060
345 GASTROENTERITIS 87 0.0060
346 BACTERIAL INFECTION 111 0.0059
347 INGUINAL HERNIA 36 0.0059
348 COELIAC DISEASE 58 0.0059
349 PSYCHOLOGICAL TRAUMA 51 0.0059
350 TENDONITIS 91 0.0059
351 TRANSIENT ISCHAEMIC ATTACK 198 0.0059
352 LUNG INFECTION 91 0.0059
353 INTERVERTEBRAL DISC PROTRUSION 128 0.0058
354 CARDIOMEGALY 72 0.0058
355 OEDEMA PERIPHERAL 710 0.0058
356 DRY THROAT 59 0.0058
357 HYPERKERATOSIS 32 0.0058
358 BIPOLAR DISORDER 63 0.0058
359 MYOPATHY 50 0.0058
360 SCAB 66 0.0058
361 VIRAL INFECTION 192 0.0058
362 AGEUSIA 143 0.0057
363 RENAL FAILURE CHRONIC 44 0.0057
364 MULTIPLE INJURIES 36 0.0057
365 HYPERTENSION 1211 0.0057
366 FACIAL PAIN 51 0.0057
367 LIMB INJURY 155 0.0057
368 OSTEOPOROSIS 234 0.0057
369 TENDON DISORDER 37 0.0057
370 ULCER 90 0.0057
371 PHARYNGEAL SWELLING 55 0.0056
372 SCRATCH 59 0.0056
373 BLOOD CREATININE INCREASED 365 0.0056
374 BLEPHAROSPASM 35 0.0056
375 MUSCULOSKELETAL CHEST PAIN 86 0.0056
376 INCREASED TENDENCY TO BRUISE 51 0.0055
377 CATARACT 330 0.0055
378 PNEUMONIA 1788 0.0055
379 HEAD DISCOMFORT 97 0.0055
380 TENDERNESS 57 0.0055
381 HEPATOTOXICITY 121 0.0054
382 BLOOD PRESSURE DIASTOLIC DECREASED 40 0.0054
383 VENTRICULAR EXTRASYSTOLES 56 0.0054
384 MUSCULOSKELETAL STIFFNESS 472 0.0054
385 BLOOD URINE PRESENT 102 0.0054
386 DIZZINESS POSTURAL 52 0.0054
387 IMPAIRED QUALITY OF LIFE 77 0.0054
388 IMPAIRED GASTRIC EMPTYING 73 0.0053
389 RESPIRATORY DISORDER 160 0.0053
390 POOR QUALITY SLEEP 115 0.0053
391 HEART RATE IRREGULAR 120 0.0053
392 SKIN SWELLING 46 0.0053
393 THROAT TIGHTNESS 143 0.0053
394 MIGRAINE 504 0.0053
395 IMMUNE SYSTEM DISORDER 69 0.0052
396 LIPASE INCREASED 40 0.0052
397 CELLULITIS 263 0.0052
398 QUALITY OF LIFE DECREASED 70 0.0052
399 ECZEMA 273 0.0052
400 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 286 0.0052
401 CHOKING 101 0.0052
402 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 37 0.0052
403 BODY TEMPERATURE INCREASED 105 0.0051
404 SCIATICA 82 0.0051
405 PHARYNGEAL OEDEMA 79 0.0051
406 HEREDITARY ANGIOEDEMA 55 0.0051
407 POOR VENOUS ACCESS 53 0.0051
408 NEPHROLITHIASIS 234 0.0051
409 CLOSTRIDIUM DIFFICILE COLITIS 54 0.0051
410 INITIAL INSOMNIA 52 0.0051
411 BREAST MASS 34 0.0051
412 BACK INJURY 55 0.0051
413 BLOOD PRESSURE INCREASED 772 0.0050
414 HEART RATE INCREASED 500 0.0050
415 PSYCHOTIC DISORDER 149 0.0050
416 GALLBLADDER DISORDER 90 0.0050
417 BLOOD BILIRUBIN INCREASED 136 0.0050
418 WOUND INFECTION 55 0.0050
419 PANIC ATTACK 183 0.0050
420 ATRIAL FIBRILLATION 487 0.0050
421 TOOTH FRACTURE 55 0.0050
422 OBSESSIVE-COMPULSIVE DISORDER 40 0.0050
423 IRRITABLE BOWEL SYNDROME 106 0.0049
424 GASTROENTERITIS VIRAL 89 0.0049
425 FORMICATION 34 0.0049
426 EYE INFECTION 55 0.0049
427 LUNG INFILTRATION 43 0.0049
428 ANXIETY 1381 0.0048
429 RIGHT VENTRICULAR FAILURE 34 0.0048
430 RENAL INJURY 144 0.0048
431 DECREASED ACTIVITY 52 0.0048
432 PALPITATIONS 562 0.0048
433 PHOTOSENSITIVITY REACTION 79 0.0048
434 ANGINA PECTORIS 137 0.0048
435 LOW DENSITY LIPOPROTEIN INCREASED 37 0.0048
436 CARDIOMYOPATHY 70 0.0047
437 ANOREXIA 61 0.0047
438 PYELONEPHRITIS 41 0.0047
439 CHEST PAIN 876 0.0047
440 INJURY 330 0.0047
441 BACK DISORDER 76 0.0047
442 HEADACHE 2919 0.0047
443 MAJOR DEPRESSION 34 0.0046
444 PRESCRIBED OVERDOSE 90 0.0046
445 DYSURIA 171 0.0046
446 HYPOAESTHESIA ORAL 70 0.0046
447 CHOLECYSTECTOMY 53 0.0046
448 HYPERGLYCAEMIA 169 0.0046
449 HEPATIC ENZYME INCREASED 316 0.0046
450 APNOEA 36 0.0046
451 PHARYNGITIS STREPTOCOCCAL 50 0.0046
452 INTRAOCULAR PRESSURE INCREASED 59 0.0046
453 NECK PAIN 258 0.0046
454 DENTAL CARIES 51 0.0046
455 SKIN FISSURES 90 0.0046
456 SPINAL COMPRESSION FRACTURE 38 0.0046
457 ARTHRITIS 361 0.0046
458 NERVE INJURY 51 0.0046
459 MUSCULOSKELETAL PAIN 240 0.0046
460 LACRIMATION INCREASED 138 0.0046
461 LYMPHADENOPATHY 161 0.0045
462 JOINT DISLOCATION 48 0.0045
463 TUBULOINTERSTITIAL NEPHRITIS 85 0.0045
464 NOCTURIA 55 0.0045
465 PRODUCT DOSE OMISSION ISSUE 1328 0.0045
466 HYPERAESTHESIA 37 0.0045
467 PLEURAL EFFUSION 274 0.0045
468 DRUG ADMINISTRATION ERROR 138 0.0045
469 BODY HEIGHT DECREASED 48 0.0045
470 INSOMNIA 1190 0.0045
471 PNEUMONIA BACTERIAL 41 0.0045
472 ARTERIAL OCCLUSIVE DISEASE 35 0.0044
473 OEDEMA 241 0.0044
474 BLOOD CHOLESTEROL INCREASED 207 0.0044
475 SOMNOLENCE 889 0.0044
476 HYPOKINESIA 64 0.0044
477 GINGIVAL PAIN 35 0.0044
478 ORAL DISCOMFORT 61 0.0044
479 LUNG NEOPLASM MALIGNANT 180 0.0044
480 GASTROINTESTINAL DISORDER 392 0.0044
481 FEELING COLD 121 0.0043
482 ACTIVITIES OF DAILY LIVING IMPAIRED 86 0.0043
483 ANKLE FRACTURE 67 0.0043
484 PULMONARY EMBOLISM 409 0.0043
485 DYSARTHRIA 162 0.0043
486 MASS 60 0.0043
487 SKIN EXFOLIATION 361 0.0043
488 DEPRESSION 972 0.0043
489 DIVERTICULITIS 118 0.0043
490 TREMOR 706 0.0042
491 ARTHROPATHY 236 0.0042
492 PARAESTHESIA ORAL 61 0.0042
493 RENAL FAILURE 561 0.0042
494 MUSCLE SPASMS 775 0.0042
495 TENDON RUPTURE 52 0.0042
496 CHOLECYSTITIS 50 0.0042
497 EYE SWELLING 156 0.0042
498 ACCIDENT 50 0.0042
499 BLOOD MAGNESIUM DECREASED 36 0.0042
500 BLOOD PRESSURE FLUCTUATION 100 0.0042
501 IMMUNODEFICIENCY 62 0.0042
502 BLOOD ALKALINE PHOSPHATASE INCREASED 103 0.0041
503 BLOOD SODIUM DECREASED 78 0.0041
504 HAIR DISORDER 34 0.0041
505 MUSCULOSKELETAL DISCOMFORT 71 0.0041
506 DEEP VEIN THROMBOSIS 268 0.0041
507 ORAL PAIN 92 0.0041
508 HAEMORRHOIDS 80 0.0041
509 ORAL HERPES 80 0.0041
510 OCULAR DISCOMFORT 46 0.0041
511 PRODUCT DISTRIBUTION ISSUE 38 0.0041
512 DEVICE DEFECTIVE 71 0.0041
513 TOOTH INFECTION 54 0.0041
514 TINNITUS 188 0.0041
515 ANAPHYLACTIC REACTION 226 0.0041
516 TOOTHACHE 74 0.0041
517 GASTRITIS 107 0.0041
518 DEPRESSED MOOD 214 0.0040
519 HEAD INJURY 128 0.0040
520 PHARMACEUTICAL PRODUCT COMPLAINT 105 0.0040
521 BLOOD LACTATE DEHYDROGENASE INCREASED 64 0.0040
522 SINUS BRADYCARDIA 39 0.0040
523 THYROID DISORDER 62 0.0040
524 INFLUENZA LIKE ILLNESS 331 0.0040
525 DERMATITIS 84 0.0040
526 EXPIRED PRODUCT ADMINISTERED 133 0.0040
527 URTICARIA 670 0.0040
528 PRODUCT PACKAGING ISSUE 38 0.0040
529 HEART RATE DECREASED 140 0.0040
530 SKIN HAEMORRHAGE 59 0.0040
531 CHILLS 465 0.0040
532 DERMATITIS ATOPIC 209 0.0040
533 INFECTION 573 0.0040
534 MUSCLE TWITCHING 91 0.0039
535 HERPES ZOSTER 226 0.0039
536 PARAESTHESIA 618 0.0039
537 WEIGHT DECREASED 1084 0.0039
538 EYE PRURITUS 130 0.0039
539 POST PROCEDURAL COMPLICATION 74 0.0038
540 POLLAKIURIA 160 0.0038
541 DRY MOUTH 311 0.0038
542 VERTIGO 233 0.0038
543 ATRIAL SEPTAL DEFECT 32 0.0038
544 NIGHT SWEATS 123 0.0038
545 THERAPEUTIC RESPONSE UNEXPECTED 171 0.0038
546 HYSTERECTOMY 33 0.0038
547 HUNGER 53 0.0038
548 JOINT RANGE OF MOTION DECREASED 51 0.0038
549 NEUROPATHY PERIPHERAL 361 0.0038
550 HELICOBACTER INFECTION 39 0.0038
551 BLOOD POTASSIUM DECREASED 114 0.0038
552 STAPHYLOCOCCAL INFECTION 125 0.0038
553 BONE DISORDER 69 0.0038
554 FEELING JITTERY 72 0.0038
555 PAIN IN JAW 107 0.0038
556 OXYGEN SATURATION DECREASED 212 0.0038
557 BACK PAIN 876 0.0038
558 UNDERDOSE 274 0.0037
559 DISCOMFORT 229 0.0037
560 RASH PRURITIC 203 0.0037
561 INFUSION RELATED REACTION 248 0.0037
562 SCAR 64 0.0037
563 PAIN IN EXTREMITY 1101 0.0037
564 FLUID RETENTION 190 0.0037
565 OCULAR HYPERAEMIA 177 0.0037
566 BLOOD PRESSURE ABNORMAL 74 0.0037
567 HYPOAESTHESIA 556 0.0037
568 SKIN ULCER 96 0.0037
569 CYSTITIS 118 0.0037
570 HEPATIC STEATOSIS 69 0.0037
571 EYE PAIN 209 0.0037
572 OVARIAN CYST 37 0.0037
573 ELECTROLYTE IMBALANCE 43 0.0037
574 DYSPEPSIA 364 0.0037
575 WEIGHT INCREASED 825 0.0037
576 SENSORY DISTURBANCE 59 0.0037
577 BREAST PAIN 39 0.0037
578 SUPRAVENTRICULAR TACHYCARDIA 35 0.0037
579 SWELLING 342 0.0037
580 CONTUSION 351 0.0036
581 GROIN PAIN 32 0.0036
582 WEIGHT FLUCTUATION 38 0.0036
583 FOLLICULITIS 38 0.0036
584 LEUKAEMIA 34 0.0036
585 METASTASES TO BONE 59 0.0036
586 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 255 0.0036
587 CORONARY ARTERY OCCLUSION 49 0.0036
588 INCORRECT DOSE ADMINISTERED 815 0.0036
589 PYREXIA 1233 0.0036
590 ERYTHEMA 730 0.0035
591 RESPIRATORY DISTRESS 98 0.0035
592 URINARY INCONTINENCE 105 0.0035
593 DIPLOPIA 92 0.0035
594 HYPERHIDROSIS 456 0.0035
595 LEUKOCYTOSIS 64 0.0035
596 FLUSHING 358 0.0035
597 CONSTIPATION 768 0.0035
598 RETCHING 75 0.0035
599 MACULAR DEGENERATION 42 0.0035
600 RASH ERYTHEMATOUS 168 0.0035
601 LACERATION 33 0.0035
602 BLISTER 197 0.0035
603 ILL-DEFINED DISORDER 213 0.0035
604 URINARY TRACT INFECTION 596 0.0035
605 MYALGIA 594 0.0035
606 CONDITION AGGRAVATED 1061 0.0035
607 SKIN DISCOLOURATION 160 0.0035
608 SPEECH DISORDER 182 0.0035
609 LOCALISED INFECTION 84 0.0035
610 DYSGEUSIA 258 0.0035
611 THIRST 62 0.0035
612 PRURITUS GENERALISED 75 0.0035
613 ILLNESS 357 0.0035
614 JOINT SWELLING 418 0.0035
615 PHOTOPHOBIA 65 0.0035
616 ABDOMINAL PAIN 803 0.0034
617 PETECHIAE 36 0.0034
618 HYPOKALAEMIA 159 0.0034
619 DEVICE DIFFICULT TO USE 228 0.0034
620 PRODUCT PRESCRIBING ISSUE 75 0.0034
621 PRURITUS 1323 0.0034
622 LOWER LIMB FRACTURE 66 0.0034
623 THINKING ABNORMAL 64 0.0034
624 RASH MACULAR 120 0.0034
625 CRYING 124 0.0034
626 MUSCULAR WEAKNESS 387 0.0034
627 INCORRECT DOSE ADMINISTERED BY DEVICE 89 0.0034
628 ADVERSE REACTION 45 0.0034
629 PROCEDURAL PAIN 94 0.0034
630 ACUTE RESPIRATORY FAILURE 65 0.0034
631 IMPAIRED WORK ABILITY 72 0.0034
632 FATIGUE 2618 0.0034
633 PULMONARY HYPERTENSION 70 0.0034
634 FEELING HOT 206 0.0034
635 MADAROSIS 39 0.0034
636 BALANCE DISORDER 289 0.0033
637 DISEASE RECURRENCE 159 0.0033
638 PRODUCT USE IN UNAPPROVED INDICATION 827 0.0033
639 WHITE BLOOD CELL COUNT INCREASED 128 0.0033
640 MOVEMENT DISORDER 107 0.0033
641 SARS-COV-2 TEST POSITIVE 44 0.0033
642 ARTHRALGIA 1385 0.0033
643 PERICARDIAL EFFUSION 77 0.0033
644 HERNIA 64 0.0033
645 FEAR 89 0.0033
646 DIABETES MELLITUS 252 0.0033
647 FALL 1100 0.0033
648 MOOD SWINGS 105 0.0033
649 TOOTH DISORDER 73 0.0033
650 ABNORMAL BEHAVIOUR 130 0.0033
651 ABDOMINAL PAIN UPPER 675 0.0033
652 SURGERY 192 0.0033
653 DERMATITIS ALLERGIC 41 0.0033
654 TREATMENT FAILURE 270 0.0033
655 SYNCOPE 326 0.0033
656 ANGER 110 0.0032
657 RENAL IMPAIRMENT 273 0.0032
658 HAEMATURIA 111 0.0032
659 DYSPHAGIA 307 0.0032
660 ACUTE KIDNEY INJURY 494 0.0032
661 WOUND 90 0.0032
662 PRESYNCOPE 78 0.0032
663 RENAL PAIN 34 0.0032
664 BASAL CELL CARCINOMA 50 0.0032
665 PERIPHERAL COLDNESS 44 0.0032
666 BLOOD CALCIUM DECREASED 36 0.0032
667 THERAPEUTIC RESPONSE DECREASED 194 0.0032
668 IMPAIRED HEALING 105 0.0032
669 GAIT DISTURBANCE 611 0.0032
670 GENERAL PHYSICAL HEALTH DETERIORATION 369 0.0032
671 THROMBOSIS 256 0.0032
672 FUNGAL INFECTION 106 0.0032
673 FEELING ABNORMAL 762 0.0032
674 MOUTH ULCERATION 67 0.0032
675 RHEUMATOID ARTHRITIS 361 0.0032
676 DISORIENTATION 125 0.0032
677 PAIN 1935 0.0031
678 GINGIVAL BLEEDING 43 0.0031
679 MUSCLE TIGHTNESS 51 0.0031
680 ABDOMINAL DISTENSION 328 0.0031
681 ATAXIA 37 0.0031
682 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 32 0.0031
683 HYPOACUSIS 134 0.0031
684 HYPERSOMNIA 89 0.0031
685 PERIPHERAL SWELLING 478 0.0031
686 MALAISE 1357 0.0031
687 SUICIDAL IDEATION 283 0.0031
688 SPINAL OPERATION 38 0.0031
689 MUSCLE ATROPHY 39 0.0031
690 HYPERCALCAEMIA 38 0.0031
691 ASTHENIA 1156 0.0031
692 INSURANCE ISSUE 47 0.0031
693 PSYCHOMOTOR HYPERACTIVITY 51 0.0031
694 GAMMA-GLUTAMYLTRANSFERASE INCREASED 68 0.0031
695 NERVOUSNESS 160 0.0031
696 KIDNEY INFECTION 60 0.0031
697 MENTAL DISORDER 133 0.0031
698 LYMPHOCYTE COUNT DECREASED 54 0.0031
699 HAIR COLOUR CHANGES 38 0.0031
700 PRODUCT USE ISSUE 573 0.0030
701 CONTRAINDICATED PRODUCT ADMINISTERED 92 0.0030
702 GLOSSODYNIA 68 0.0030
703 DEVICE DISLOCATION 132 0.0030
704 STOMATITIS 184 0.0030
705 CLOSTRIDIUM DIFFICILE INFECTION 66 0.0030
706 DIZZINESS 1507 0.0030
707 RASH 1316 0.0030
708 THERAPEUTIC RESPONSE SHORTENED 100 0.0030
709 GASTROINTESTINAL PAIN 33 0.0030
710 BRAIN FOG 47 0.0030
711 URINARY RETENTION 100 0.0030
712 ANAPHYLACTIC SHOCK 77 0.0030
713 HOT FLUSH 225 0.0030
714 EMOTIONAL DISORDER 92 0.0030
715 NAUSEA 2359 0.0030
716 LIMB DISCOMFORT 92 0.0030
717 SKIN DISORDER 99 0.0030
718 PULMONARY ARTERIAL HYPERTENSION 43 0.0030
719 UPPER LIMB FRACTURE 59 0.0030
720 EYE DISORDER 97 0.0029
721 HYPONATRAEMIA 166 0.0029
722 COAGULOPATHY 49 0.0029
723 ROAD TRAFFIC ACCIDENT 123 0.0029
724 AGGRESSION 147 0.0029
725 DYSKINESIA 119 0.0029
726 INTENTIONAL PRODUCT MISUSE 256 0.0029
727 HAIR TEXTURE ABNORMAL 39 0.0029
728 INTENTIONAL PRODUCT USE ISSUE 255 0.0029
729 INFLAMMATION 150 0.0029
730 SPINAL PAIN 34 0.0029
731 ABNORMAL DREAMS 80 0.0029
732 MOBILITY DECREASED 208 0.0029
733 COLD SWEAT 51 0.0029
734 OSTEONECROSIS 95 0.0029
735 ANAEMIA 551 0.0029
736 BLOOD CREATINE PHOSPHOKINASE INCREASED 83 0.0029
737 ADVERSE EVENT 265 0.0029
738 PRODUCT PHYSICAL ISSUE 58 0.0029
739 FLATULENCE 163 0.0029
740 ASPARTATE AMINOTRANSFERASE INCREASED 152 0.0029
741 PAIN OF SKIN 77 0.0029
742 BONE PAIN 167 0.0028
743 MUSCLE SPASTICITY 35 0.0028
744 BLOOD PRESSURE DECREASED 189 0.0028
745 VISION BLURRED 389 0.0028
746 BLOOD TRIGLYCERIDES INCREASED 50 0.0028
747 CARDIAC FAILURE CONGESTIVE 227 0.0028
748 HAEMATOMA 73 0.0028
749 MYOCARDIAL ISCHAEMIA 32 0.0028
750 ALANINE AMINOTRANSFERASE INCREASED 172 0.0028
751 COVID-19 PNEUMONIA 33 0.0028
752 EMOTIONAL DISTRESS 338 0.0028
753 WRONG TECHNIQUE IN DRUG USAGE PROCESS 101 0.0028
754 TACHYCARDIA 247 0.0028
755 BONE DENSITY DECREASED 87 0.0028
756 HAEMATOCRIT DECREASED 55 0.0028
757 PULMONARY OEDEMA 124 0.0028
758 MEDICATION ERROR 153 0.0027
759 LOCAL SWELLING 48 0.0027
760 BLOOD UREA INCREASED 46 0.0027
761 SPINAL FRACTURE 55 0.0027
762 HIP ARTHROPLASTY 42 0.0027
763 HOSPITALISATION 420 0.0027
764 SYSTEMIC LUPUS ERYTHEMATOSUS 97 0.0027
765 SPLENOMEGALY 32 0.0027
766 DISABILITY 54 0.0027
767 COLITIS 103 0.0027
768 APHASIA 82 0.0027
769 DRUG PRESCRIBING ERROR 52 0.0027
770 HALLUCINATION, AUDITORY 43 0.0027
771 RESTLESSNESS 99 0.0027
772 AMNESIA 175 0.0027
773 NIGHTMARE 93 0.0027
774 SKIN BURNING SENSATION 192 0.0027
775 MULTIPLE FRACTURES 44 0.0027
776 DEAFNESS 70 0.0027
777 HEMIPARESIS 45 0.0027
778 COVID-19 466 0.0027
779 DRY SKIN 354 0.0026
780 IRRITABILITY 159 0.0026
781 ORTHOSTATIC HYPOTENSION 46 0.0026
782 EJECTION FRACTION DECREASED 41 0.0026
783 DYSSTASIA 77 0.0026
784 ABDOMINAL DISCOMFORT 441 0.0026
785 VOMITING 1234 0.0026
786 NO THERAPEUTIC RESPONSE 32 0.0026
787 EYE IRRITATION 151 0.0026
788 INCREASED APPETITE 50 0.0026
789 CHROMATURIA 59 0.0026
790 LIP SWELLING 87 0.0026
791 PANCREATITIS 138 0.0026
792 PARANOIA 45 0.0026
793 GASTRIC DISORDER 89 0.0026
794 ABASIA 64 0.0026
795 BEDRIDDEN 34 0.0026
796 DEHYDRATION 345 0.0026
797 C-REACTIVE PROTEIN INCREASED 94 0.0026
798 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 465 0.0026
799 SKIN CANCER 55 0.0026
800 OSTEOMYELITIS 46 0.0025
801 UNEVALUABLE EVENT 192 0.0025
802 DEVICE BREAKAGE 103 0.0025
803 DIARRHOEA 1637 0.0025
804 VISUAL ACUITY REDUCED 84 0.0025
805 LIVER DISORDER 112 0.0025
806 SEPSIS 281 0.0025
807 FREQUENT BOWEL MOVEMENTS 68 0.0025
808 INCORRECT PRODUCT ADMINISTRATION DURATION 54 0.0025
809 ARRHYTHMIA 118 0.0025
810 EATING DISORDER 53 0.0025
811 DISTURBANCE IN ATTENTION 134 0.0025
812 VISUAL IMPAIRMENT 306 0.0025
813 MOOD ALTERED 67 0.0025
814 RENAL FAILURE ACUTE 104 0.0024
815 THERAPEUTIC PRODUCT EFFECT DECREASED 109 0.0024
816 RASH MACULO-PAPULAR 54 0.0024
817 EPILEPSY 74 0.0024
818 ACUTE MYOCARDIAL INFARCTION 71 0.0024
819 LIVER FUNCTION TEST ABNORMAL 70 0.0024
820 BONE LOSS 36 0.0024
821 PSORIATIC ARTHROPATHY 97 0.0024
822 ALOPECIA 468 0.0024
823 DELUSION 37 0.0024
824 UPPER GASTROINTESTINAL HAEMORRHAGE 40 0.0024
825 HALLUCINATION 179 0.0024
826 KNEE ARTHROPLASTY 50 0.0024
827 HAEMOGLOBIN DECREASED 243 0.0024
828 INJECTION SITE URTICARIA 58 0.0024
829 APPLICATION SITE PAIN 52 0.0024
830 CYANOSIS 37 0.0024
831 MENTAL IMPAIRMENT 57 0.0023
832 INTENTIONAL DOSE OMISSION 67 0.0023
833 DRUG INEFFECTIVE 3094 0.0023
834 ERUCTATION 45 0.0023
835 FEMUR FRACTURE 72 0.0023
836 HAEMATOCHEZIA 128 0.0023
837 RASH GENERALISED 60 0.0023
838 EXPOSURE DURING PREGNANCY 144 0.0023
839 GASTRIC ULCER 44 0.0023
840 DRUG ERUPTION 41 0.0023
841 JAUNDICE 62 0.0023
842 RESPIRATORY FAILURE 166 0.0023
843 RASH PAPULAR 51 0.0023
844 MENTAL STATUS CHANGES 63 0.0023
845 LOSS OF CONSCIOUSNESS 290 0.0023
846 OSTEONECROSIS OF JAW 56 0.0023
847 DIABETES MELLITUS INADEQUATE CONTROL 40 0.0023
848 MENORRHAGIA 44 0.0022
849 RED BLOOD CELL COUNT DECREASED 64 0.0022
850 DRUG EFFECT LESS THAN EXPECTED 33 0.0022
851 INJECTION SITE PRURITUS 149 0.0022
852 DECREASED APPETITE 515 0.0022
853 GASTROINTESTINAL HAEMORRHAGE 185 0.0022
854 MEMORY IMPAIRMENT 304 0.0022
855 HYPERTHYROIDISM 32 0.0022
856 CARDIOVASCULAR DISORDER 56 0.0022
857 EXPOSURE VIA SKIN CONTACT 57 0.0022
858 DRUG EFFECT DECREASED 117 0.0022
859 HYPOTENSION 434 0.0022
860 PSORIASIS 282 0.0022
861 SEROTONIN SYNDROME 41 0.0021
862 PALLOR 58 0.0021
863 INJECTION SITE BRUISING 170 0.0021
864 LETHARGY 122 0.0021
865 TREATMENT NONCOMPLIANCE 116 0.0021
866 VENTRICULAR TACHYCARDIA 35 0.0021
867 INJECTION SITE SWELLING 160 0.0021
868 AGITATION 153 0.0021
869 FACE OEDEMA 35 0.0021
870 RECTAL HAEMORRHAGE 89 0.0021
871 HEPATITIS 53 0.0021
872 ABSCESS 33 0.0021
873 CONFUSIONAL STATE 334 0.0021
874 ERECTILE DYSFUNCTION 53 0.0021
875 PNEUMONITIS 56 0.0021
876 EXTRAPYRAMIDAL DISORDER 51 0.0021
877 CONVULSION 117 0.0020
878 PELVIC PAIN 37 0.0020
879 GAIT INABILITY 68 0.0020
880 TARDIVE DYSKINESIA 57 0.0020
881 INTENTIONAL DRUG MISUSE 42 0.0020
882 ADVERSE DRUG REACTION 179 0.0020
883 ACCIDENTAL EXPOSURE TO PRODUCT 205 0.0020
884 HYPOGLYCAEMIA 96 0.0020
885 PRODUCT DOSE OMISSION IN ERROR 56 0.0020
886 FEEDING DISORDER 40 0.0020
887 OFF LABEL USE 1724 0.0020
888 INTESTINAL OBSTRUCTION 74 0.0020
889 INJECTION SITE ERYTHEMA 242 0.0019
890 BLOOD GLUCOSE ABNORMAL 36 0.0019
891 INJECTION SITE WARMTH 40 0.0019
892 MUSCULOSKELETAL DISORDER 37 0.0019
893 INJECTION SITE REACTION 132 0.0019
894 JOINT STIFFNESS 50 0.0019
895 BREAST CANCER 177 0.0019
896 ABDOMINAL PAIN LOWER 48 0.0019
897 PRODUCT PRESCRIBING ERROR 45 0.0019
898 PRODUCT DISPENSING ERROR 41 0.0019
899 PRODUCT ADMINISTRATION ERROR 38 0.0019
900 HYPOPHAGIA 48 0.0019
901 TASTE DISORDER 38 0.0019
902 HIP FRACTURE 60 0.0019
903 COGNITIVE DISORDER 87 0.0019
904 HEPATIC CIRRHOSIS 35 0.0019
905 PRODUCT SUBSTITUTION ISSUE 107 0.0019
906 PROTEINURIA 35 0.0018
907 INJECTION SITE MASS 68 0.0018
908 APPLICATION SITE ERYTHEMA 48 0.0018
909 NERVOUS SYSTEM DISORDER 57 0.0018
910 UNRESPONSIVE TO STIMULI 47 0.0018
911 INJECTION SITE PAIN 557 0.0018
912 DRUG INTERACTION 288 0.0018
913 FAECES DISCOLOURED 39 0.0018
914 WITHDRAWAL SYNDROME 75 0.0018
915 MULTIPLE ORGAN DYSFUNCTION SYNDROME 50 0.0018
916 INCORRECT ROUTE OF DRUG ADMINISTRATION 63 0.0018
917 CEREBROVASCULAR ACCIDENT 298 0.0018
918 MYOCARDIAL INFARCTION 304 0.0017
919 SEIZURE 201 0.0017
920 MELAENA 38 0.0017
921 FEBRILE NEUTROPENIA 114 0.0017
922 COLITIS ULCERATIVE 75 0.0017
923 INJECTION SITE RASH 51 0.0017
924 WHITE BLOOD CELL COUNT DECREASED 180 0.0017
925 PANCREATITIS ACUTE 37 0.0016
926 NEUTROPHIL COUNT DECREASED 67 0.0016
927 TOOTH LOSS 34 0.0016
928 DRUG EFFECT INCOMPLETE 59 0.0016
929 CARDIAC FAILURE 130 0.0016
930 HAEMATEMESIS 41 0.0016
931 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 324 0.0016
932 ASCITES 47 0.0016
933 GLYCOSYLATED HAEMOGLOBIN INCREASED 40 0.0016
934 MATERNAL EXPOSURE DURING PREGNANCY 140 0.0016
935 HYPERKALAEMIA 55 0.0016
936 BLOOD GLUCOSE DECREASED 75 0.0016
937 LABORATORY TEST ABNORMAL 46 0.0016
938 INTERNATIONAL NORMALISED RATIO INCREASED 44 0.0015
939 ACNE 117 0.0015
940 HAEMORRHAGE 159 0.0015
941 INCORRECT DRUG ADMINISTRATION DURATION 42 0.0015
942 DEPRESSED LEVEL OF CONSCIOUSNESS 59 0.0015
943 INJECTION SITE HAEMORRHAGE 118 0.0015
944 BLINDNESS 60 0.0015
945 DRUG EXPOSURE DURING PREGNANCY 50 0.0015
946 EXTRA DOSE ADMINISTERED 59 0.0015
947 PANCYTOPENIA 81 0.0014
948 ACCIDENTAL OVERDOSE 53 0.0014
949 BRADYCARDIA 76 0.0014
950 DEMENTIA 40 0.0014
951 SEPTIC SHOCK 62 0.0014
952 CARDIAC ARREST 115 0.0014
953 PLATELET COUNT DECREASED 148 0.0014
954 CEREBRAL HAEMORRHAGE 48 0.0013
955 MULTIPLE SCLEROSIS 64 0.0013
956 SEDATION 35 0.0013
957 VAGINAL HAEMORRHAGE 58 0.0013
958 DELIRIUM 46 0.0013
959 RHABDOMYOLYSIS 55 0.0013
960 DEVICE ISSUE 118 0.0013
961 BLOOD GLUCOSE INCREASED 244 0.0013
962 THROMBOCYTOPENIA 140 0.0013
963 THERAPY CESSATION 63 0.0012
964 MUCOSAL INFLAMMATION 32 0.0012
965 INTERSTITIAL LUNG DISEASE 59 0.0012
966 NEEDLE ISSUE 34 0.0012
967 OVERDOSE 250 0.0012
968 NEOPLASM MALIGNANT 77 0.0012
969 DEVICE LEAKAGE 50 0.0012
970 SKIN IRRITATION 52 0.0011
971 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 33 0.0011
972 LEUKOPENIA 54 0.0011
973 PLASMA CELL MYELOMA 42 0.0011
974 DRUG DEPENDENCE 173 0.0011
975 ABORTION SPONTANEOUS 43 0.0011
976 DISEASE PROGRESSION 123 0.0010
977 MULTIPLE SCLEROSIS RELAPSE 69 0.0010
978 CARDIO-RESPIRATORY ARREST 42 0.0010
979 ELECTROCARDIOGRAM QT PROLONGED 36 0.0010
980 MALIGNANT NEOPLASM PROGRESSION 97 0.0009
981 THERAPY NON-RESPONDER 41 0.0009
982 THERAPY INTERRUPTED 64 0.0009
983 SUICIDE ATTEMPT 54 0.0009
984 DRUG WITHDRAWAL SYNDROME 71 0.0008
985 FOETAL EXPOSURE DURING PREGNANCY 61 0.0007
986 NEUTROPENIA 99 0.0007
987 DEATH 623 0.0007
988 TOXICITY TO VARIOUS AGENTS 89 0.0005
989 INTENTIONAL OVERDOSE 33 0.0005
990 DRUG DOSE OMISSION BY DEVICE 40 0.0005
991 PROSTATE CANCER 36 0.0004
992 PRODUCT STORAGE ERROR 33 0.0004